Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

Experts across healthcare debunk 15 common myths about GLP-1 medications—covering everything from access and cost to ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may ...

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

Ozempic has already taken the world by storm as a weight loss game-changer, but now, scientists say its impact might go much deeper than the number on the scale. New research suggests that this widely ...

Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...

Ozempic (semaglutide) and Trulicity (dulaglutide) are brand-name subcutaneous injections. They’re both prescribed for adults with type 2 diabetes who may or may not have certain cardiovascular ...

Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage cover various diabetes-related costs, including Trulicity. Out-of-pocket costs may apply.

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...